Literature DB >> 23124416

Influence of age, performance status, cancer activity, and IL-6 on anxiety and depression in patients with metastatic breast cancer.

C F Jehn1, B Flath, A Strux, M Krebs, K Possinger, A Pezzutto, D Lüftner.   

Abstract

Depression and anxiety are the core disorders causing emotional distress in patients (pts) with metastatic breast cancer. The aim of our study was to screen metastatic breast cancer outpatients for anxiety and depression, and to investigate the influence of age, Karnofsky Performance Status (KPS), cancer activity, and inflammation as represented by IL-6 levels on these two mood disorders. Pts treated with chemotherapy for metastatic breast cancer (n = 70) were assessed using the Hospital Anxiety and Depression Scale (HADS) for symptoms (scores 0-21) and caseness (score ≥11) of clinical depression and anxiety. Blood samples for IL-6 concentrations were collected at 10:00 a.m. A total of 22 (31.4 %) pts were diagnosed with caseness of clinical depression and 23 (32.9 %) pts with clinical anxiety, while 12 pts were diagnosed positive for both mood disorders. Depression and anxiety were positively but moderately correlated (Spearman's r (2) = 0.24, p < 0.001). IL-6 was significantly correlated with symptoms of depression (r (2) = 0.42, p < 0.001) and to a lesser extent to symptoms of anxiety (r (2) = 0.16, p = 0.001). In addition, IL-6 was positively associated with tumor progression (p < 0.001). Multiple linear regression analysis showed that tumor progression (standardized b = 0.226, p = 0.047), symptoms of anxiety (b = 0.292, p = 0.016), and IL-6 (b = 0.314, p = 0.007) were independently associated with clinical depression, whereas anxiety was linked to tumor progression (b = 0.238, p = 0.030), symptoms of depression (b = 0.407, p < 0.001) and age (b = -0.381, p < 0.001), but not to IL-6 (b = 0.168, p = 0.134). Even though a positive correlation between depression and anxiety exists, clinical parameters like age, cancer activity, KPS, and IL-6 do influence depression and anxiety differently. Unlike clinical depression, anxiety is not associated with increased IL-6 levels, however, shows a reciprocal correlation with age.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23124416     DOI: 10.1007/s10549-012-2311-2

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  27 in total

1.  The impact of mode of presentation on distress in patients with early stage breast cancer.

Authors:  L Jane McSweeney; D O'Mahony; J E Battley; E Lee; L Nagle; S O'Reilly
Journal:  Ir J Med Sci       Date:  2017-01-07       Impact factor: 1.568

2.  Implementation and Feasibility of Electronic Patient-Reported Outcome (ePRO) Data Entry in the PRAEGNANT Real-Time Advanced and Metastatic Breast Cancer Registry.

Authors:  Markus Wallwiener; Felix Heindl; Sara Y Brucker; Florin-Andrei Taran; Andreas Hartkopf; Friedrich Overkamp; Hans-Christian Kolberg; Peyman Hadji; Hans Tesch; Johannes Ettl; Michael P Lux; Claudia Rauh; Simon Blum; Naiba Nabieva; Tobias F Brodkorb; Cornelia Faschingbauer; Hanna Langemann; Carla Schulmeyer; Bernhard Volz; Matthias Rübner; Diana Lüftner; Volkmar Müller; Erik Belleville; Wolfgang Janni; Tanja N Fehm; Diethelm Wallwiener; Thomas Ganslandt; Matthias W Beckmann; Andreas Schneeweiss; Peter A Fasching; Paul Gass
Journal:  Geburtshilfe Frauenheilkd       Date:  2017-08-24       Impact factor: 2.915

3.  Anxiety and Depression in Young Women With Metastatic Breast Cancer: A Cross-Sectional Study.

Authors:  Eliza M Park; Shari Gelber; Shoshana M Rosenberg; Davinia S E Seah; Lidia Schapira; Steven E Come; Ann H Partridge
Journal:  Psychosomatics       Date:  2018-01-31       Impact factor: 2.386

4.  Co-occurrence of anxiety and depressive symptoms following breast cancer surgery and its impact on quality of life.

Authors:  Marshall Gold; Laura B Dunn; Bethany Phoenix; Steven M Paul; Deborah Hamolsky; Jon D Levine; Christine Miaskowski
Journal:  Eur J Oncol Nurs       Date:  2015-07-15       Impact factor: 2.398

5.  Interleukin-6 and tumor necrosis factor-α are associated with quality of life-related symptoms in pulmonary arterial hypertension.

Authors:  Lea Ann Matura; Corey E Ventetuolo; Harold I Palevsky; David J Lederer; Evelyn M Horn; Stephen C Mathai; Diane Pinder; Christine Archer-Chicko; Emilia Bagiella; Kari E Roberts; Russell P Tracy; Paul M Hassoun; Reda E Girgis; Steven M Kawut
Journal:  Ann Am Thorac Soc       Date:  2015-03

6.  Cancer-related inflammation and depressive symptoms: Systematic review and meta-analysis.

Authors:  Daniel C McFarland; Meredith Doherty; Thomas M Atkinson; Robin O'Hanlon; William Breitbart; Christian J Nelson; Andrew H Miller
Journal:  Cancer       Date:  2022-04-13       Impact factor: 6.921

7.  Prevalence of anxiety and depression and their risk factors in Chinese cancer patients.

Authors:  Jin Sheng Hong; Jun Tian
Journal:  Support Care Cancer       Date:  2013-10-04       Impact factor: 3.603

8.  Metastatic Breast Cancer Collateral Damage Project (MBCCD): Scale development and preliminary results of the Survey of Health, Impact, Needs, and Experiences (SHINE).

Authors:  Timothy J Williamson; Susan M Love; Jessica N Clague DeHart; Alexandra Jorge-Miller; Leah Eshraghi; Heather Cooper Ortner; Annette L Stanton
Journal:  Breast Cancer Res Treat       Date:  2018-05-16       Impact factor: 4.872

9.  Early childhood adversity in adult patients with metastatic lung cancer: Cross-sectional analysis of symptom burden and inflammation.

Authors:  Daniel C McFarland; Christian Nelson; Andrew H Miller
Journal:  Brain Behav Immun       Date:  2020-08-11       Impact factor: 7.217

10.  Inflammatory biomarkers, geriatric assessment, and treatment outcomes in acute myeloid leukemia.

Authors:  Kah Poh Loh; Janet A Tooze; Barbara J Nicklas; Stephen B Kritchevsky; Jeff D Williamson; Leslie R Ellis; Bayard L Powell; Timothy S Pardee; Neha G Goyal; Heidi D Klepin
Journal:  J Geriatr Oncol       Date:  2019-04-05       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.